PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
批准号:
6510813
负责人:
Anthony T Vella
金额:
$27.65万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2004-06-30
关键词:
BCL2 gene /protein CD antigens T lymphocyte apoptosis cytokine cytokine receptors genetically modified animals immunomodulators interleukin 1 interleukin 6 laboratory mouse leukocyte activation /transformation lipopolysaccharides polymerase chain reaction tissue /cell culture tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
For many years it has been well known that injection of antigen into
animals leads to the activation and proliferation of CD4 bearing T
cells. Once the activated T cells have clonally expanded to a maximal
level, the majority of them go on to die via apoptosis. This event
raises the problem of how antigen-primed T cells ever survive long
enough to develop into memory cells. Thus many of these T cells must be
able to resist death otherwise a memory response directed towards the
antigen would never occur. Recently, it has been shown that T cell
clonal expansion in the face of an inflammatory response prevents the
death of activated T cells. Therefore, T cells that respond to antigen
at an inflammatory site will be spared from activation-induced death. It
has been proposed that the activated T cells receive a survival signal
which deregulates the death program. For example, co-injection of an
antigen with the pro-inflammatory bacterial byproduct,
lipopolysaccharide (LPS), leads to long-term T cell survival of the
antigen responsive cells. Furthermore, LPS injection conditions these
cells to resist FAS-based death. The nature of the T cell survival
signal is unknown. The experiments in this project are designed to
uncover the underpinnings of this signal. It is known, however, that LPS
does not directly condition the activated T cell, therefore, there must
be downstream mediators that interact with the activated T cells and
uncouple their death pathways. In this study we will determine which
factors induced by lipopolysaccharide are essential for rescuing
antigen-activated T cells from death. Both in vivo and in vitro
experiments will be conducted to determine which cytokines induced by
LPS are essential to block death and which death pathways are
deregulated in the rescued T cells. A hallmark of a health immune system
is the ability to discern self antigen from foreign antigen. All to
often a breakdown in tolerance to self antigen occurs which can lead to
autoimmune disease. In many cases autoimmunity is associated with
inflammatory responses and the effects of inflammation on adaptive
immunity are not well understood. The studies described here will lead
to a better understanding of the relationship between inflammatory
processes and T cell survival. Ultimately these studies may provide a
better understanding on how T cells are activated to protect a host from
an invading pathogen and how T cells fail self tolerance in the
periphery and become autoreactive.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10571689
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
MiR-150 regulated adiose tissue B cells in obesity
-
批准号:10357914
-
项目类别:
-
资助金额:$41.0万
-
财政年份:2020
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:9920669
-
项目类别:
-
资助金额:$39.88万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
IRAK4 and Systemic Lupus Erythematosus
-
批准号:10118270
-
项目类别:
-
资助金额:$40.96万
-
财政年份:2018
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6702215
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:9055615
-
项目类别:
-
资助金额:$266.91万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7023905
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6614049
-
项目类别:
-
资助金额:$13.59万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8661689
-
项目类别:
-
资助金额:$266.08万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:8414902
-
项目类别:
-
资助金额:$252.35万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Modulation of Biodefense Responses to Microbial Pathogens
-
批准号:9268551
-
项目类别:
-
资助金额:$266.75万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:7184441
-
项目类别:
-
资助金额:$30.93万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Impact of Staphylococcus Aureus enterotoxin on pulmonary inflamation
-
批准号:8424005
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the Mechanism of 4-1BB Constimulatiuon
-
批准号:6846020
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2003
-
负责人:Anthony T Vella
-
依托单位:
Understanding the mechanism of 4-1BB costimulation
-
批准号:6506130
-
项目类别:
-
资助金额:$32.63万
-
财政年份:2002
-
负责人:Anthony T Vella
-
依托单位:
PROINFLAMMATORY CYTOKINES BLOCK T CELL DEATH IN VIVO
-
批准号:6541284
-
项目类别:
-
资助金额:$25.85万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7447415
-
项目类别:
-
资助金额:$33.72万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:7256916
-
项目类别:
-
资助金额:$34.37万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8918772
-
项目类别:
-
资助金额:$5.78万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
How Proinflammatory Cytokines Block T Cell Death In Vivo
-
批准号:8628022
-
项目类别:
-
资助金额:$38.26万
-
财政年份:1999
-
负责人:Anthony T Vella
-
依托单位:
海外基金